ALCON INC (2U3.DE) Stock Price & Overview
FRA:2U3 • CH0432492467
Current stock price
The current stock price of 2U3.DE is 62.6 EUR. Today 2U3.DE is down by -0.22%. In the past month the price decreased by -2.43%.
2U3.DE Key Statistics
- Market Cap
- 31.281B
- P/E
- 23.98
- Fwd P/E
- 21.47
- EPS (TTM)
- 2.61
- Dividend Yield
- 0.48%
2U3.DE Stock Performance
2U3.DE Stock Chart
2U3.DE Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to 2U3.DE.
2U3.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to 2U3.DE. 2U3.DE has an excellent financial health rating, but there are some minor concerns on its profitability.
2U3.DE Earnings
On February 24, 2026 2U3.DE reported an EPS of 0.78 and a revenue of 2.70B. The company missed EPS expectations (-1.57% surprise) and missed revenue expectations (-1.53% surprise).
2U3.DE Forecast & Estimates
20 analysts have analysed 2U3.DE and the average price target is 91.81 EUR. This implies a price increase of 46.66% is expected in the next year compared to the current price of 62.6.
For the next year, analysts expect an EPS growth of 11.48% and a revenue growth 7.24% for 2U3.DE
2U3.DE Financial Highlights
Over the last trailing twelve months 2U3.DE reported a non-GAAP Earnings per Share(EPS) of 2.61. The EPS increased by 0.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.42% | ||
| ROA | 3.11% | ||
| ROE | 4.45% | ||
| Debt/Equity | 0.21 |
2U3.DE Ownership
2U3.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1EL | ESSILORLUXOTTICA | 23.77 | 84.249B | ||
| EL | ESSILORLUXOTTICA | 23.69 | 83.971B | ||
| ESL | ESSILORLUXOTTICA | 23.5 | 83.3B | ||
| CVX | CARVOLIX SA | N/A | 167.649M | ||
| GBT | GUERBET | N/A | 146.624M | ||
| ALCJ | CROSSJECT | 7.11 | 101.083M | ||
| PTP | PENTIXAPHARM HOLDING AG | N/A | 50.096M | ||
| SVS | SVAS BIOSANA SPA | 5.99 | 49.504M |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 2U3.DE
Company Profile
Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. The company is headquartered in Fribourg, Fribourg and currently employs 25,942 full-time employees. The company went IPO on 2019-04-09. The firm research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The firm operates in 60 countries and serves consumers and patients in over 140 countries.
Company Info
IPO: 2019-04-09
ALCON INC
Rue Louis d'Affry 6
Fribourg FRIBOURG CH
Employees: 25942
Phone: 41589112222
ALCON INC / 2U3.DE FAQ
What does ALCON INC do?
Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. The company is headquartered in Fribourg, Fribourg and currently employs 25,942 full-time employees. The company went IPO on 2019-04-09. The firm research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The firm operates in 60 countries and serves consumers and patients in over 140 countries.
What is the current price of 2U3 stock?
The current stock price of 2U3.DE is 62.6 EUR. The price decreased by -0.22% in the last trading session.
Does 2U3 stock pay dividends?
ALCON INC (2U3.DE) has a dividend yield of 0.48%. The yearly dividend amount is currently 0.29.
What is the ChartMill technical and fundamental rating of 2U3 stock?
2U3.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What is the Price/Earnings (PE) ratio of ALCON INC (2U3.DE)?
The PE ratio for ALCON INC (2U3.DE) is 23.98. This is based on the reported non-GAAP earnings per share of 2.61 and the current share price of 62.6 EUR.
Is ALCON INC (2U3.DE) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 2U3.DE.